The size of the Middle East and Africa PET Scanners Market is projected to value USD 85.56 million by 2029 from USD 75.44 million in 2024, growing at a CAGR of 2.55% during the forecast period.
The hybrid imaging using combined scanners, like SPECT/CT, PET/CT, and PET/MRI, is likely to propel future growth. In addition, arsenic 72 and (18F)-3’-fluoro-3’-deoxythymidine (18F-FLT) are newer biomarkers in the PET oncological practice. In addition, the increase in the use of PET-CT for cancer diagnosis is expected to boost the market growth further. Furthermore, the rise in prevalence of chronic illnesses throughout the region is majorly influencing the market growth in the region. Also, the growth in demand for effective diagnostic systems increased coverage for PET-CT scanning under Medicare, and growing awareness about the pet imaging techniques are expected to boost the market.
Moreover, the advancement of newer products and increasing investments by the government and private organizations to develop healthcare infrastructure influence market growth during the forecast period. For example, hybrid imaging, which combines PET and X-ray transmission CT scans, is becoming more popular throughout the region due to its ability to reduce acquisition time and offer precise attenuation correction and fusion imaging, resulting in improved diagnostic sensitivity and specificity. Furthermore, establishing guidelines for the manufacture of radiopharmaceuticals is projected to contribute to the market's development. The International Atomic Energy Agency, for example, authorized a project in February 2020 to provide support and expertise in the manufacturing of cyclotron-based gallium-68 radioisotope and associated radiopharmaceuticals.
Furthermore, the major companies in Middle East Arica are conducting research and development activities that contribute toward the market's revenue growth. In addition, the growing adoption of dual-modality imaging techniques or hybrid imaging is most likely to provide significant opportunities for key market players in the region; thereby, the market expansion is making possible.
However, continuous reimbursement cutbacks are expected to hinder the growth of the market. Patient access to high-quality, cost-effective imaging and diagnostic services has been affected by declining payer reimbursement for PET and SPECT treatments, resulting in decreased outpatient volumes. However, limited shelf life and inadequate availability of radiopharmaceuticals are expected to restrict the market growth.
Oncology
Neurology
Partial Ring PET Scanners
Full Ring PET Scanners
Gadolinium Oxyorthosilicate
Lutetium Fine Silicate
Diagnostic Centres
Hospitals
KSA
The market growth is attributed to the proliferation of chronic diseases and the growing demand for effective diagnostic systems across the region. Further, the advancement of new products by the regional market players is augmenting the market growth. The presence of key market players such as Saudi Arabia, UAE, and Saudi Arabia majorly contributes to the MEA regional market growth. The increase in population and shift towards good quality healthcare facilities in the emerging countries these countries. South Africa dominated the market growth with a significant market over in the previous year. An increase in the quality of healthcare facilities and improving healthcare expenditure, and developing infrastructure are propelling the market growth in the region.
Some of the key players operating in the MEA PET scanners market analyzed in this report are Positron Corporation, Mediso Ltd., Siemens AG, Hitachi, Ltd., General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., and Yangzhou Kindsway Biotech Co. Ltd., among others.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region